Status:
COMPLETED
The Role Of Cognitive Impairment In The Use Of The Diskus Inhaler
Lead Sponsor:
Synergy Health Solutions
Conditions:
Cognitive Impairment
Eligibility:
All Genders
18+ years
Brief Summary
The Diskus Inhaler is administered by a nurse or medical technician in the Nursing Home (NH) setting. The administration of the medication from the Diskus Inhaler includes 4 steps: open, click, inhale...
Detailed Description
Background and Objectives: Approximately 1.6 million geriatric nursing home (NH) residents are living in about 17,000 Nursing Homes in the United States. This population (including those who live in ...
Eligibility Criteria
Inclusion
- Adult men and women residing in a NH or ALF
- Mini Mental Status Exam (MMSE) score between 10 and 24 inclusive
- Able to hold breath for at least 10 seconds
- Able to speak and understand English
Exclusion
- Current or history of Diskus use
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00891059
Start Date
May 1 2009
End Date
July 1 2009
Last Update
November 23 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooksville Health Care Center
Brooksville, Florida, United States, 34601
2
Bethany Village
Centerville, Ohio, United States, 45459